Marc Schwabish
CIK: 0002023175
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Tectonic Therapeutic, Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Sep 25, 2026TECX
Tectonic Therapeutic, Inc.
Tax Payment(F)Direct411 shares at avg. $23.67$10K - Sep 3, 2026TECX
Tectonic Therapeutic, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
17.8K shares- - Mar 4, 2026TECX
Tectonic Therapeutic, Inc.
Award(A)Direct19.5K shares- - Feb 10, 2026TECX
Tectonic Therapeutic, Inc.
Exercise(M)Direct4.5K shares at avg. $2.38$11K - Feb 4, 2026TECX
Tectonic Therapeutic, Inc.
Tax Payment(F)Direct1.6K shares at avg. $23.22$38K - Sep 25, 2025TECX
Tectonic Therapeutic, Inc.
Award(A)Direct4.2K shares- - Feb 4, 2025TECX
Tectonic Therapeutic, Inc.
Award(A)Direct14K shares- - Jan 28, 2025TECX
Tectonic Therapeutic, Inc.
Exercise(M)Direct2.7K shares at avg. $2.38$6K - Dec 9, 2024TECX
Tectonic Therapeutic, Inc.
Exercise(M)Direct2K shares at avg. $2.38$5K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 25, 2026 | TECX Tectonic Therapeutic, Inc. | Tax Payment(F) | 411 | $23.67 | $9,728 | Direct |
| Sep 3, 2026 | TECX Tectonic Therapeutic, Inc. | Award(A) Employee Stock Option (Right to Buy) | 17,750 | - | - | Direct |
| Mar 4, 2026 | TECX Tectonic Therapeutic, Inc. | Award(A) | 19,500 | - | $0 | Direct |
| Feb 10, 2026 | TECX Tectonic Therapeutic, Inc. | Exercise(M) | 4,500 | $2.38 | $10,710 | Direct |
| Feb 4, 2026 | TECX Tectonic Therapeutic, Inc. | Tax Payment(F) | 1,619 | $23.22 | $37,593 | Direct |
| Sep 25, 2025 | TECX Tectonic Therapeutic, Inc. | Award(A) | 4,210 | - | - | Direct |
| Feb 4, 2025 | TECX Tectonic Therapeutic, Inc. | Award(A) | 14,023 | - | - | Direct |
| Jan 28, 2025 | TECX Tectonic Therapeutic, Inc. | Exercise(M) | 2,700 | $2.38 | $6,426 | Direct |
| Dec 9, 2024 | TECX Tectonic Therapeutic, Inc. | Exercise(M) | 2,000 | $2.38 | $4,760 | Direct |
1-9 of 9 transactions
About Schwabish Marc
Schwabish Marc (SEC CIK 0002023175) files insider reports with the SEC as Chief Business Officer of Tectonic Therapeutic, Inc. (TECX).
Signal8 holds 9 ownership filings by Schwabish Marc, all Form 4s, filed between Dec 11, 2024 and Oct 2, 2026. Those filings report 9 transactions, from Dec 9, 2024 to Sep 25, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Schwabish Marc's filings is in WATERTOWN, MA.
Recent filings by Schwabish Marc
- Sep 25, 2026: Tax withholding of TECX shares (Form 4, code F).
- Sep 3, 2026: Grant or award of TECX derivative securities (Form 4, code A).
- Mar 4, 2026: Grant or award of TECX shares (Form 4, code A).
- Feb 10, 2026: Option exercise of TECX shares (Form 4, code M).
- Feb 4, 2026: Tax withholding of TECX shares (Form 4, code F).
Other insiders filing for Tectonic Therapeutic, Inc. (TECX)
- REICIN ALISE, Chief Executive Officer
- Lochner Daniel, Chief Financial Officer
- McNamara Peter, Chief Scientific Officer
- Ruddy Marcella K., Chief Medical Officer
- SPRINGER TIMOTHY A, Director
- Tipirneni Praveen P., Director